eligibility for clinicaltrials:NCT00727038 [clinicaltrials_resource:5608ca1f2795d64bc8b6cf8d48bea5a6]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT00727038 [clinicaltrials_resource:5608ca1f2795d64bc8b6cf8d48bea5a6]
Bio2RDF identifier
5608ca1f2795d64bc8b6cf8d48bea5a6
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5608ca1f2795d64bc8b6cf8d48bea5a6
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
minimum age [clinicaltrials_vocabulary:minimum-age]
text [clinicaltrials_vocabulary:text]
Inclusion Criteria:
...... or bevacizumab in either eye.
identifier
clinicaltrials_resource:5608ca1f2795d64bc8b6cf8d48bea5a6
title
eligibility for clinicaltrials:NCT00727038
@en
type
label
eligibility for clinicaltrials ...... 8ca1f2795d64bc8b6cf8d48bea5a6]
@en